A Multicenter Randomized Double-blind Placebo-controlled Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX Followed by an Optional Open-Label Treatment with BOTOX in Female Subjects with Interstitial Cystitis/Blad

Brief description of study

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX®, Followed by an Optional Open-Label Treatment with BOTOX®, in Female Subjects with Interstitial Cystitis/Blad


Clinical Study Identifier: s22-00322
ClinicalTrials.gov Identifier: NCT05141006
Principal Investigator: Benjamin M. Brucker.
Other Investigator: Lauren E. Stewart.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.